Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2026-07-06 20:40:23 ET · period of report 2026-07-01 · accession 0001493152-26-032235 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-06 20:40 | 2026-07-01 | IMDX | SILVERMAN LOU | Dir | F - Tax | $5.69 | -7,700 | 55.8K | -12% | -$43.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2026-07-01 | F | D | 7,700 | $5.69 | 55,807 | D | — | — | (F1) The reported disposition reflects shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of 35,000 shares of restricted stock units granted to the reporting person on July 1, 2025. The reporting person did not sell any shares. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. |